DigestRedComo funciona
Red
/
Empresas
Ve
No verificado

Vertex Pharmaceuticals Incorporated

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

62 Comunicados de prensa

Ver todos los comunicados de prensa
06/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Vertex to Announce First Quarter 2026 Financial Results on May 4th
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
01/04/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Sanidad
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
09/03/2026
Multimedia
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
05/03/2026
Eventos
Ciencia
Cardiología
Biotecnología
Farmacéutica
Salud
Vertex to Participate in Upcoming March Investor Conferences
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
05/03/2026
Eventos
Industria
Ciencia
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Salud
Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
17/02/2026
Salud
Sanidad
Farmacéutica
Cardiología
Biotecnología
Eventos
Web y redes sociales
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
12/02/2026
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Web y redes sociales
Telefonía
Mercado de valores
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
20/01/2026
Ciencia
Material médico sanitario
Salud
Medicina - Varios
Biotecnología
Farmacéutica
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
11/01/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Eventos
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
22/12/2025
Biotecnología
Salud
Ciencia
Farmacéutica
Eventos
Web y redes sociales
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0